Table of Contents
Statin Alternatives: Understanding Some Options for Cholesterol Management
Managing cholesterol is a central concern for millions of people worldwide, and statin alternatives have become an increasingly discussed topic as patients and healthcare providers look for the right approach to lipid management. Whether due to side effects, personal preference, or the need for additional cholesterol-lowering support, understanding the landscape of statin alternatives is an important step in making informed decisions about cardiovascular health. This article explores how statins work, reviews the major prescription medications that exist outside of the statin drug class, and examines where nattokinase supplements may help support a healthy lifestyle.
What Are Statins and How Do They Work
Statins are a class of prescription medications that have been the standard of care for managing high cholesterol for several decades. They work by inhibiting an enzyme in the liver called HMG-CoA reductase, which plays a key role in the body's production of cholesterol. By reducing the liver's ability to produce cholesterol internally, statins cause the liver to increase the number of LDL receptors on its surface. This, in turn, pulls more LDL cholesterol out of the bloodstream, resulting in lower circulating LDL levels. Common statins include atorvastatin, rosuvastatin, and simvastatin, among others.
Statins have been widely studied and are associated with reductions in the risk of heart attack, stroke, and other cardiovascular events in clinical trials. They are generally considered first-line therapy for individuals with elevated LDL cholesterol or a history of cardiovascular disease. However, some patients experience side effects such as muscle pain, an increased risk of developing diabetes, or digestive discomfort, which can lead them and their healthcare providers to explore statin alternatives.
Prescription Statin Alternatives: Other Cholesterol-Lowering Medications
For patients who cannot tolerate statins or who need additional LDL-lowering support, several other prescription medication classes exist. Each works through a different mechanism to reduce cholesterol levels.
Ezetimibe
Ezetimibe works by blocking the absorption of cholesterol in the small intestine, specifically by inhibiting a protein called NPC1L1. When less cholesterol is absorbed from food, the liver compensates by pulling more LDL cholesterol from the blood, which lowers circulating LDL levels. Research has shown ezetimibe can reduce LDL cholesterol by approximately 15 to 22 percent when used alone and can provide additional reductions when combined with a statin. It is generally well tolerated, with large randomized trials showing side effect profiles similar to placebo. Ezetimibe is often considered one of the first statin alternatives prescribed by healthcare providers.
PCSK9 Inhibitors
PCSK9 inhibitors, including alirocumab and evolocumab, represent a newer class of injectable medications. They work by blocking a protein called PCSK9, which normally degrades LDL receptors on the surface of liver cells. By inhibiting PCSK9, these medications allow more LDL receptors to remain active, which increases the clearance of LDL cholesterol from the blood. Studies suggest PCSK9 inhibitors can reduce LDL cholesterol by 50 to 60 percent. A newer form of this approach, inclisiran, uses small interfering RNA technology to silence the PCSK9 gene and is administered as an injection twice per year. Drawbacks of PCSK9 inhibitors include high cost and the need for injections, along with potential injection site reactions.
Bempedoic Acid
Bempedoic acid is another option among statin alternatives that works in the liver by inhibiting ATP citrate lyase, an enzyme involved in cholesterol synthesis. Importantly, bempedoic acid is activated only in the liver and does not enter muscle cells, which means it may be better suited for patients who have experienced statin-related muscle complaints. It has been shown to reduce LDL cholesterol by approximately 17 to 28 percent. Side effects may include gout, mild changes in kidney function markers, and gallbladder inflammation.
Bile Acid Sequestrants
Bile acid sequestrants, such as cholestyramine and colesevelam, work by binding to bile acids in the intestine and preventing their reabsorption. Since bile acids are made from cholesterol, the liver must use more cholesterol from the blood to produce new bile acids, thereby lowering LDL levels. These medications can lower LDL cholesterol by 10 to 30 percent. However, they can cause gastrointestinal side effects including constipation and bloating, may require multiple doses per day, and can increase triglyceride levels in some individuals.
Fibrates and Omega-3 Fatty Acids
Fibrates such as fenofibrate and gemfibrozil primarily target triglyceride levels and have a modest effect on LDL cholesterol. Prescription-strength omega-3 fatty acid preparations, such as icosapent ethyl, are used mainly to reduce elevated triglycerides and are sometimes combined with statins. Neither fibrates nor omega-3 fatty acids are typically considered primary statin alternatives for LDL reduction, but they play a role in managing overall lipid profiles for certain patients.
Where Nattokinase Fits In
Nattokinase is a fermented soybean-derived enzyme (our nattokinase supplement is soy-free, made with fermented chickpeas) that has received attention in the context of cardiovascular health research. It is important to understand that nattokinase is not a statin alternative in the clinical sense. It is classified as a dietary supplement, not an FDA-approved medication, and it has not undergone the same level of large-scale clinical testing that prescription statin alternatives have.
That said, research has explored several potential mechanisms by which nattokinase may influence cardiovascular health. Nattokinase is best known for its fibrinolytic activity, meaning it has the ability to break down fibrin, a protein involved in blood clot formation. Some research has also investigated its potential effects on lipid levels. A review published in PMC noted that nattokinase may influence lipid metabolism through several pathways, including activating hormone-sensitive lipase, enhancing lipoprotein lipase activity, and potentially inhibiting HMG-CoA reductase, the same enzyme targeted by statins.
A 2022 clinical study involving 1,062 participants, published in Frontiers in Cardiovascular Medicine, examined the effects of nattokinase supplementation at 10,800 FU per day over 12 months and observed changes in lipid profiles and plaque measurements in participants with pre-existing conditions.
A 2023 systematic review and meta-analysis of randomized controlled trials published in Reviews in Cardiovascular Medicine examined data from six studies with 546 participants and found that the effects of nattokinase on lipid parameters appeared to be dose-dependent, with lower dosages showing limited lipid-lowering effects.
However, there are important differences between nattokinase and prescription statin alternatives. The body of evidence supporting nattokinase is considerably smaller (more on nattokinase benefits here), most studies have had limited sample sizes, and many of the mechanisms by which nattokinase may affect lipid metabolism have not been fully established through rigorous mechanism experiments. Additionally, nattokinase may interact with blood-thinning medications, which is a significant consideration for anyone already managing cardiovascular conditions.
Toku Flow | Nattokinase Supplement (10,800 FU)
$179.97
Find Your Flow A daily powdered supplement designed to promote clear, efficient blood flow and circulation, ensuring vital nutrients reach your heart and organs while supporting your body’s ability to clear metabolic waste for sustained vitality and overall wellness.… read more
Making Informed Decisions About Statin Alternatives
The landscape of statin alternatives is broader today than it has ever been. From prescription medications like ezetimibe, PCSK9 inhibitors, and bempedoic acid to supplements like nattokinase that are the subject of ongoing research, there are many options that patients and healthcare providers can discuss together. Each approach has its own mechanism of action, level of supporting evidence, potential benefits, and potential drawbacks.
Anyone exploring statin alternatives should have a thorough conversation with their healthcare provider about their individual risk factors, medical history, and goals. Cholesterol management is not a one-size-fits-all situation, and the right approach depends on each person's unique circumstances.
